identifier NCT#

Related by string. * iden tified . identi fied . Identifier . IDENTIFIED . IDentifier . Identified : unique identifier . identifi cation . Crash Identified . Veuillez vous identifier dans . Suspect Identified / : ClinicalTrials.gov identifier NCT# . NCT# ClinicalTrials.gov . number NCT# ClinicalTrials.gov . NCT# . ID NCT# * ClinicalTrials.gov Identifier NCT# . study identifier NCT# *

Related by context. Frequent words. (Click for all words.) 76 http:/www.clinicaltrials.gov 74 www.clinicaltrials.gov 73 clinicaltrials.gov 69 NCT# 67 ClinicalTrials.gov 65 www.incyte.com 64 http:/www.ariad.com 64 www.cardiome.com 64 Full Prescribing Information 64 www.cancer.gov 64 www.allos.com 64 www.syntapharma.com 63 www.vical.com 62 www.questcor.com 61 Phase III Clinical Trial 61 www.ziopharm.com 61 www.biosantepharma.com 61 www.aidshealth.org 61 Phase Ib II 61 Phase IIIb 61 Pivotal Phase III 60 phase IIb clinical 60 www.gsk.com 60 www.delcath.com 60 www.labopharm.com 59 www.caliperLS.com 59 www.gpc biotech.com 59 refractory chronic lymphocytic 59 forodesine 59 Phase Ib clinical 58 Metastatic Melanoma 58 Completes Enrollment 58 Patient Enrollment 58 Pivotal Trial 58 www.aethlonmedical.com 58 clevudine 58 Phase IIB 58 multicenter clinical 58 Clinical Study 58 II Clinical Trial 58 optimal dosing 58 Initiate Phase 58 phase IIa clinical 58 Presents Positive 57 Allovectin 7 R 57 Clinical Trial Results 57 PUBMED 57 www.udetection.com 57 Prescribing Information 57 Chronic Heart Failure 57 Preclinical Data 57 CR# vcMMAE 57 ThermoDox R 56 Phase III Trial 56 Pulmonary Arterial Hypertension 56 ganetespib 56 Phase 1b trial 56 phase IIa 56 rNAPc2 56 FDA Accepts 56 Azedra 56 Pivotal Phase 55 Drug Candidate 55 Daclizumab 55 FavId 55 Golimumab 55 Acute Myocardial Infarction 55 TYGACIL 55 Phase Ia 55 Patient Registry 55 Visit www.qsii.com 55 Entereg R 55 KRN# 55 Factor VIIa 55 placebo controlled clinical 55 phase Ib 55 http:/www.nice.com 55 IMC #B 55 BLA submission 55 Prostate Cancer Patients 55 www.fei.com 55 Gastric Cancer 55 Phase 2b clinical trials 55 Benign Prostatic Hyperplasia 55 Solid Tumors 55 www.ovt.com 55 Lovaxin C 54 www.fticonsulting.com 54 EVEREST II 54 Telavancin 54 Virulizin R 54 Investigational Device Exemption 54 www.idc.com 54 Prostate Cancer Treatment 54 teduglutide 54 TELCYTA 54 Diabetic Patients 54 NCCTG 54 CrossRef Web 54 relapsed refractory multiple myeloma 54 Pirfenidone

Back to home page